Valuation: Kindstar Globalgene Technology, Inc.

Market Cap 765M 895M 114M 101M 94.63M 86.25M 163M 10.97B 164M 1.15B 444M 5.61B 428M 419M 18B P/E 2024
-19.2x
P/E 2025 -17x
Enterprise Value -424M -496M -63.23M -56.18M -52.44M -47.79M -90.14M -6.08B -90.98M -635M -246M -3.11B -237M -232M -9.97B EV / Sales 2024
-0.19x
EV / Sales 2025 -0.2x
Free-Float
48.15%
Yield 2024
2.02%
Yield 2025 8.48%
1 day-2.70%
1 week-5.26%
Current month-2.70%
1 month-6.25%
3 months-8.16%
6 months-21.74%
Current year-19.64%
1 week 0.9
Extreme 0.895
0.95
1 month 0.9
Extreme 0.895
0.96
Current year 0.9
Extreme 0.895
1.3
1 year 0.9
Extreme 0.895
1.56
3 years 0.9
Extreme 0.895
1.79
5 years 0.9
Extreme 0.895
6.36
10 years 0.9
Extreme 0.895
9.78
Manager TitleAgeSince
Chief Executive Officer 68 2021-02-07
Director of Finance/CFO 48 2021-02-07
Chief Tech/Sci/R&D Officer - 2024-09-26
Director TitleAgeSince
Chairman 68 2021-02-07
Director/Board Member 54 2020-12-03
Director/Board Member 48 2020-12-03
Date Insider Type Main position Quantity % Market Cap. Importance
7/13/22 Other 500 0.0001% -
7/12/22 Other 65,000 0.0065%
7/11/22 Other 100,000 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
-2.70%-5.26%-40.79%-44.44% 114M
+1.48%-3.00%+11.58%+24.85% 111B
+0.78%-2.05%-0.66%+74.89% 92.38B
+0.46%-0.54%+145.20%+833.67% 59.15B
-0.38%-5.45%-7.47%+54.41% 27.66B
+0.97%-1.27%+30.11%+92.79% 25.75B
+1.28%-0.37%+11.39%+53.88% 25.02B
-0.67%-0.58%-16.34%-7.26% 20.99B
+1.83%-0.42%+27.40%+309.14% 20.82B
+1.30%-2.86%-4.06%+34.25% 16.87B
Average +0.44%-2.18%+15.64%+142.62% 39.93B
Weighted average by Cap. +0.89%-2.05%+27.08%+177.99%

Financials

2024 2025
Net sales 928M 1.09B 138M 123M 115M 105M 197M 13.3B 199M 1.39B 538M 6.8B 519M 508M 21.82B 934M 1.09B 139M 124M 115M 105M 198M 13.39B 200M 1.4B 541M 6.84B 523M 511M 21.96B
Net income -54.59M -63.89M -8.14M -7.23M -6.75M -6.15M -11.61M -783M -11.71M -81.71M -31.66M -400M -30.57M -29.9M -1.28B -58.74M -68.75M -8.76M -7.78M -7.27M -6.62M -12.49M -842M -12.61M -87.92M -34.07M -431M -32.89M -32.18M -1.38B
Net Debt -1.26B -1.47B -188M -167M -156M -142M -267M -18.03B -270M -1.88B -729M -9.22B -704M -689M -29.58B -1.19B -1.39B -177M -158M -147M -134M -253M -17.05B -255M -1.78B -690M -8.72B -666M -651M -27.97B
Logo Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology Inc is an investment holding company engaged in the provision of clinical testing services. The Company includes nine segments. The Hematology Testing segment includes testing services related to blood diseases. The Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. The Infectious Diseases segment includes testing services from the infection department. The Oncology segment includes testing related to oncology diseases. The Neurology segment includes testing services related to neurological diseases. The Maternity-Related Diseases segment includes testing services related to maternity. The Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Scientific Research Services and Cro segment includes research and development services. The Others segment provides other miscellaneous testing services.
Employees
2,999
Date Price Change Volume
26-10-02 HK$0.9000 -2.70% 199,500
26-09-30 HK$0.9250 +1.09% 107,500
26-09-29 HK$0.9150 0.00% 112,000
26-09-28 HK$0.9150 -3.68% 141,500
26-09-25 HK$0.9500 +1.60% 54,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9960 Stock